Current Liabilities
Other Commercial Liabilities
Labcorp Holdings Other Commercial Liabilities increased by 0.5% to $851.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.6%, from $770.40M to $851.90M. Over 5 years (FY 2020 to FY 2025), Other Commercial Liabilities shows a downward trend with a -9.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ4 2014
Last reportedQ3 2024
Metric ID:
commercial_liabilities_otherHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.32B | $1.42B | $1.40B | $1.26B | $1.14B | $1.04B | $787.00M | $929.50M | $657.80M | $689.70M | $804.00M | $649.30M | $707.50M | $757.50M | $871.20M | $770.40M | $835.80M | $878.00M | $847.80M | $851.90M |
| QoQ Change | — | +8.0% | -1.4% | -10.2% | -9.6% | -8.7% | -24.4% | +18.1% | -29.2% | +4.8% | +16.6% | -19.2% | +9.0% | +7.1% | +15.0% | -11.6% | +8.5% | +5.0% | -3.4% | +0.5% |
| YoY Change | — | — | — | — | -13.5% | -26.9% | -43.9% | -26.3% | -42.3% | -33.7% | +2.2% | -30.1% | +7.6% | +9.8% | +8.4% | +18.7% | +18.1% | +15.9% | -2.7% | +10.6% |
Range$649.30M – $1.42B
CAGR-8.8%
Avg YoY Growth-8.0%
Median YoY Growth-0.3%
Other Commercial Liabilities at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's other commercial liabilities?
- Labcorp Holdings (LH) reported other commercial liabilities of $851.90M in Q1 2026.
- How has Labcorp Holdings's other commercial liabilities changed year-over-year?
- Labcorp Holdings's other commercial liabilities increased by 10.6% year-over-year, from $770.40M to $851.90M.
- What is the long-term trend for Labcorp Holdings's other commercial liabilities?
- Over 5 years (2020 to 2025), Labcorp Holdings's other commercial liabilities has grown at a -9.0% compound annual growth rate (CAGR), from $1.36B to $847.80M.